Inactive Instrument

News La Jolla Pharmaceutical Company

Equities

LJPC

US5034596040

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K	22-08-22	PU
LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-08-22	AQ
La Jolla Pharmaceutical Announces Management Changes	22-08-22	CI
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from NASDAQ Composite Index	22-08-22	CI
La Jolla Pharmaceutical Company(NasdaqCM:LJPC) dropped from S&P TMI Index	22-08-22	CI
Innoviva, Inc. completed the acquisition of La Jolla Pharmaceutical Company for approximately $210 million.	22-08-21	CI
LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-15	AQ
Tranche Update on La Jolla Pharmaceutical Company's Equity Buyback Plan announced on November 17, 2021.	22-08-15	CI
La Jolla Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC	22-07-11	BU
Twitter, Las Vegas Sands fall; Mullen, La Jolla rise	22-07-11	AQ
Sector Update: Health Care Stocks Edging Lower at Close	22-07-11	MT
Top Midday Gainers	22-07-11	MT
Sector Update: Health Care Stocks Still Little Changed	22-07-11	MT
Sector Update: Health Care	22-07-11	MT
Innoviva Agrees to Take La Jolla Pharmaceutical Private in $149 Million Acquisition Deal; Shares Rise	22-07-11	MT
La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K	22-07-11	PU
LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
Innoviva to Acquire La Jolla Pharmaceutical Company	22-07-11	BU
La Jolla Pharmaceutical Company Equity Buyback announced on November 17, 2021, has expired, in connection with the announced merger, the stock repurchase plan was cancelled effective July 11, 2022.	22-07-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News La Jolla Pharmaceutical Company

Equities

LJPC

US5034596040

Summary

Filters